Co-Authors
This is a "connection" page, showing publications co-authored by Roberto Giacomelli and Francesco Ursini.
Connection Strength
2.920
-
Fibromyalgia: a new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021 08; 7(3).
Score: 0.240
-
Isolated "puffy hands" following COVID-19: clue to a long-term capillary leakage syndrome? Clin Rheumatol. 2021 09; 40(9):3863-3864.
Score: 0.238
-
Broad clinical spectrum of SARS-CoV-2-associated inflammatory joint disease in adults: a report of 35 cases from the COVID-19 & Autoimmune Systemic Disease Italian study group. Ann Rheum Dis. 2021 11; 80(11):1498-1501.
Score: 0.237
-
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1247-1254.
Score: 0.229
-
Levels and Factors Associated with Resilience in Italian Healthcare Professionals during the COVID-19 Pandemic: A Web-Based Survey. Behav Sci (Basel). 2020 Nov 29; 10(12).
Score: 0.229
-
Rheumatic manifestations of COVID-19: a systematic review and meta-analysis. BMC Rheumatol. 2020; 4:65.
Score: 0.228
-
The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review. Autoimmun Rev. 2019 May; 18(5):501-509.
Score: 0.203
-
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study. Medicine (Baltimore). 2019 Feb; 98(7):e14587.
Score: 0.202
-
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis. Autoimmun Rev. 2019 Jan; 18(1):93-106.
Score: 0.198
-
The effect of non-TNF-targeted biologics and small molecules on insulin resistance in inflammatory arthritis. Autoimmun Rev. 2018 Apr; 17(4):399-404.
Score: 0.189
-
Biologic drugs in adult onset Still's disease: a systematic review and meta-analysis of observational studies. Expert Rev Clin Immunol. 2017 11; 13(11):1089-1097.
Score: 0.184
-
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. Medicine (Baltimore). 2017 Aug; 96(34):e7896.
Score: 0.182
-
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. PLoS One. 2017; 12(7):e0181203.
Score: 0.181
-
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. Autoimmun Rev. 2017 Sep; 16(9):911-924.
Score: 0.181